C07C 323/30
Having the sulfur atom of at least one of the thio groups
Official title: having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
C07C323/30 (Having the sulfur atom of at least one of the thio groups) appears on 42 US grants and 46 published applications in this corpus.
Search patents in C07C- Granted patents
- 42
- Published applications
- 46
- Assignees
- 41
- Inventors
- 167
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 4 |
| 2003 | 1 | 1 |
| 2004 | 1 | 2 |
| 2005 | 2 | 3 |
| 2006 | 1 | 0 |
| 2007 | 0 | 4 |
| 2008 | 1 | 3 |
| 2009 | 7 | 4 |
| 2010 | 5 | 3 |
| 2011 | 1 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 2 |
| 2022 | 3 | 4 |
| 2023 | 0 | 4 |
| 2024 | 3 | 6 |
| 2025 | 0 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Hydroxynorketamine analogues, compositions comprising same and methods of use thereof16 Jun 2026US 12,655,089 B2Spirify Pharma Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents22 Oct 2024US 12,121,591 B2NanoVation Therapeutics Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives30 Jul 2024US 12,049,439 B2OrsoBio, Inc.
- Expectorant compound, preparation method thereof and use thereof28 May 2024US 11,993,561 B2Hc Synthetic Pharmaceutical Co., Ltd.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives12 Dec 2024US 2024/0409508 A1OrsoBio, Inc.
- Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents5 Dec 2024US 2024/0398977 A1NanoVation Therapeutics Inc.
- Novel compound for capping layer and organic light emitting device including same22 Aug 2024US 2024/0279158 A1Dongjin Semichem Co., Ltd.
- Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents8 Aug 2024US 2024/0261430 A1NanoVation Therapeutics Inc.
Most cited
By later US patents
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- N-acylsulfonamide apoptosis promoters54US 6,720,338 B2Abbott Laboratories · 2004
- N-acylsulfonamide apoptosis promoters43US 7,504,512 B2Abbott Laboratories · 2009
- N-acylsulfonamide apoptosis promoters29US 7,754,886 B2Abbott Laboratories · 2010
- Compounds useful in pain management21US 6,498,196 B12002